Chemical and Drug Induced Liver Injury

"Chemical and Drug Induced Liver Injury" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.

Descriptor ID	D056486
MeSH Number(s)	C06.552.195 C25.100.562 C25.723.260
Concept/Terms	Chemical and Drug Induced Liver Injury Chemical and Drug Induced Liver Injury Chemically-Induced Liver Toxicity Chemically-Induced Liver Toxicity Chemically Induced Liver Toxicity Chemically-Induced Liver Toxicities Liver Toxicities, Chemically-Induced Liver Toxicity, Chemically-Induced Toxicities, Chemically-Induced Liver Toxicity, Chemically-Induced Liver Drug-Induced Acute Liver Injury Drug-Induced Acute Liver Injury Drug Induced Acute Liver Injury Liver Injury, Drug-Induced, Acute Acute Liver Injury, Drug-Induced Acute Liver Injury, Drug Induced Hepatitis, Toxic Hepatitis, Toxic Toxic Hepatitis Hepatitides, Toxic Toxic Hepatitides Drug-Induced Liver Disease Drug-Induced Liver Disease Disease, Drug-Induced Liver Diseases, Drug-Induced Liver Drug Induced Liver Disease Drug-Induced Liver Diseases Liver Disease, Drug-Induced Liver Diseases, Drug-Induced Drug-Induced Liver Injury Drug Induced Liver Injury Drug-Induced Liver Injuries Injuries, Drug-Induced Liver Injury, Drug-Induced Liver Liver Injuries, Drug-Induced Liver Injury, Drug-Induced Liver Injury, Drug Induced Hepatitis, Drug-Induced Hepatitis, Drug-Induced Drug-Induced Hepatitides Drug-Induced Hepatitis Hepatitides, Drug-Induced Hepatitis, Drug Induced

Below are MeSH descriptors whose meaning is more general than "Chemical and Drug Induced Liver Injury".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Chemical and Drug Induced Liver Injury [C06.552.195]
Chemically-Induced Disorders [C25]
Drug-Related Side Effects and Adverse Reactions [C25.100]
Chemical and Drug Induced Liver Injury [C25.100.562]
Poisoning [C25.723]
Chemical and Drug Induced Liver Injury [C25.723.260]

Below are MeSH descriptors whose meaning is related to "Chemical and Drug Induced Liver Injury".

Below are MeSH descriptors whose meaning is more specific than "Chemical and Drug Induced Liver Injury".

Chemical and Drug Induced Liver Injury
Chemical and Drug Induced Liver Injury, Chronic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Chemical and Drug Induced Liver Injury" by people in this website by year, and whether "Chemical and Drug Induced Liver Injury" was a major or minor topic of these publications.

Bar chart showing 30 publications over 19 distinct years, with a maximum of 3 publications in 2011 and 2016 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	1	1
2002	1	0	1
2003	2	0	2
2007	1	0	1
2008	1	0	1
2009	1	0	1
2010	2	0	2
2011	3	0	3
2012	2	0	2
2013	1	0	1
2014	1	1	2
2015	1	1	2
2016	2	1	3
2017	1	0	1
2018	1	0	1
2019	1	0	1
2020	3	0	3
2021	0	1	1

Below are the most recent publications written about "Chemical and Drug Induced Liver Injury" by people in Profiles.

Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH. Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. Drug Saf. 2021 10; 44(10):1109-1119.

View in: PubMed
Schneider KM, Elfers C, Ghallab A, Schneider CV, Galvez EJC, Mohs A, Gui W, Candels LS, Wirtz TH, Zuehlke S, Spiteller M, Myllys M, Roulet A, Ouzerdine A, Lelouvier B, Kilic K, Liao L, Nier A, Latz E, Bergheim I, Thaiss CA, Hengstler JG, Strowig T, Trautwein C. Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury. Cell Mol Gastroenterol Hepatol. 2021; 11(4):909-933.

View in: PubMed
Lu Y, Wu Y, Chen X, Yang X, Xiao H. Water extract of shepherd's purse prevents high-fructose induced-liver injury by regulating glucolipid metabolism and gut microbiota. Food Chem. 2021 Apr 16; 342:128536.

View in: PubMed
Dai J, Yang X, Yuan Y, Jia Y, Liu G, Lin N, Xiao H, Zhang L, Chen J. Toxicity, gut microbiota and metabolome effects after copper exposure during early life in SD rats. Toxicology. 2020 03 30; 433-434:152395.

View in: PubMed
Carreiro S, Marvel-Coen J, Lee R, Chapman B, Ambros V. Circulating microRNA Profiles in Acetaminophen Toxicity. J Med Toxicol. 2020 04; 16(2):177-187.

View in: PubMed
Khan FS, Akram M, Aslam N, Zaheer J, Mustafa SB, Kausar S, Khan AH, Khan IA, Munir N, Shah SMA, Tahir IM, Sharif A. Phytochemical analysis and hepatoprotective effect of polyherbal formulation on CCl4 induced hepatotoxicity in mice. Pak J Pharm Sci. 2018 Nov; 31(6 (Supplementary):2719-2723.

View in: PubMed
Iracheta-Vellve A, Szabo G. IL-1? in acetaminophen toxicity: a sterile danger signal. Cell Mol Immunol. 2018 Mar; 15(3):284-285.

View in: PubMed
Iracheta-Vellve A, Petrasek J, Gyongyosi B, Satishchandran A, Lowe P, Kodys K, Catalano D, Calenda CD, Kurt-Jones EA, Fitzgerald KA, Szabo G. Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes. J Biol Chem. 2016 Dec 23; 291(52):26794-26805.

View in: PubMed
Lampson BL, Kasar SN, Matos TR, Morgan EA, Rassenti L, Davids MS, Fisher DC, Freedman AS, Jacobson CA, Armand P, Abramson JS, Arnason JE, Kipps TJ, Fein J, Fernandes S, Hanna J, Ritz J, Kim HT, Brown JR. Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. Blood. 2016 07 14; 128(2):195-203.

View in: PubMed
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016 May; 3(5):e217-27.

View in: PubMed

People

Explore

Similar Concepts

Top Journals